Article information
Full text is only aviable in PDF
Bibliografía
[3.]
W.W. Busse.
Current research and future needs in allergic rhinitis and asthma.
J Allerg Clin Immunol, 101 (1998), pp. S424-S426
[4.]
Global Strategy for Asthma Management and, Prevention., WHO/NHLBI., workshop report publication n.o 1995 95-3675
[5.]
J. Mullol.
Rinitis. Aspectos generales de su etiología, fisiopatología, diagnóstico y tratamiento.
Asma, 3 (1996), pp. 21-26
[6.]
R.F. Lemanske Jr..
A review of the current guidelines for allergic rhinitis and asthma.
J Allergy Clin Immunol, 101 (1998), pp. S392-S396
[7.]
P. Van Cauwenberge, C. Bachert, G. Passalacqua, J. Bousquet, G.W. Canonica, S.R. Durham, et al.
Consensus statement on the treatment of allergic rhinitis.
Allergy, 55 (2000), pp. 116-134
[9.]
European Allergy White, Paper., UCB., Institute of Allergy 1997.
[10.]
J. Mackoviak.
The health and economic impact of rhinitis: a roundtable discusion.
Am J Managed Care, 3 (1997), pp. S8-S18
[11.]
Alergológica factores epidemiológicos clínicos y socioeconómicos de las enfermedades alérgicas en España.
NILO Industria Gráfica, (1995),
[12.]
Anónimo.
Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS).
Eur Respir J, 9 (1996), pp. 687-695
[13.]
E.F. Juniper.
Impact of upper respiratory allergic disease on quality of life.
J Allergy Clin Immunol, 101 (1998), pp. S386-S391
[14.]
D. Smith, D. Malone, K. Lawson.
A national stimate of the economic costs of asthma.
Am J Respir Crit Care Med, 156 (1997), pp. 787-793
[15.]
T. Levenson, P.A. Greenberger.
Pathophysiology and therapy for allergic and nonallergic rhinitis: an updated review.
Allergy Asthma Proc, 18 (1997), pp. 213-220
[16.]
S.R. Durham.
Mechanisms of mucosal inflammation in the nose and lungs.
Clin Exp Allergy, 28 (1998), pp. 11-16
[17.]
B.A. Galen.
Differential diagnosis. Rhinitis.
Lippincotts Prim Care Pract, 1 (1997), pp. 129-141
[18.]
International Rhinitis Management Working Group.
International consensus report on the diagnosis and Management of, Rhinitis.
Allergy, 49 (1994), pp. 5-34
[19.]
H. Milgrom, B. Bender.
Adverser effects of medications for rhinitis.
Ann Allergy Asthma Immunol, 78 (1997), pp. 439-444
[20.]
D.W. Aaronson.
Side effects of rhinitis medications.
J Allergy Clin Immunol, 101 (1998), pp. S379-S382
[21.]
J. Mullol, L. Pujols, C. Picado.
Mecanismos de acción de los glucocorticoides Aplicación al tratamiento de la inflamación respiratoria. 1996.
Arch Bronconeumol, 32 (1996), pp. 527-534
[22.]
G. Passalaqua, M. Albano, G.W. Canonica, C. Bachert, P. Van Cauwenberge, R.J. Davies, et al.
Inhaled and nasal corticosteroids: safety aspects.
Allergy, 55 (2000), pp. 16-33
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica
